The Performance of the Mologic Biomarker Panel in Infection

UnknownOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

November 26, 2017

Primary Completion Date

April 30, 2019

Study Completion Date

July 31, 2019

Conditions
SepsisInfection
Interventions
DIAGNOSTIC_TEST

Mologic Biomarker Panel

In brief the proposed biomarkers will be measured in the laboratory of Mologic . These will initially be performed using standard lab assays (Enzyme Linked Immunosorbent Assays, ELISA). Biomarkers that show promise will then be mounted on a novel lateral flow device (under development), that could ultimately be deployed at the patients bedside.

Trial Locations (1)

NW1 2BU

RECRUITING

University College London Hospital, London

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

University College London Hospitals

OTHER

collaborator

Innovate UK

OTHER_GOV

lead

Mologic Ltd

INDUSTRY

NCT03217552 - The Performance of the Mologic Biomarker Panel in Infection | Biotech Hunter | Biotech Hunter